Total Payments
$208,708
2024 Payments
$7,710
Companies
27
Transactions
386
Medicare Patients
4,284
Medicare Billing
$676,780
Payment Breakdown by Category
Consulting$172,015 (82.4%)
Other$22,590 (10.8%)
Food & Beverage$6,594 (3.2%)
Travel$5,078 (2.4%)
Research$2,415 (1.2%)
Education$15.35 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $172,015 | 109 | 82.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $17,590 | 11 | 8.4% |
| Food and Beverage | $6,594 | 241 | 3.2% |
| Travel and Lodging | $5,078 | 20 | 2.4% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $5,000 | 2 | 2.4% |
| Unspecified | $2,415 | 2 | 1.2% |
| Education | $15.35 | 1 | 0.0% |
Payments by Type
General
$206,293
384 transactions
Research
$2,415
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| CapsoVision, Inc. | $152,050 | 102 | $0 (2024) |
| Medtronic, Inc. | $23,712 | 25 | $0 (2022) |
| Synergy Pharmaceuticals Inc | $10,483 | 21 | $0 (2018) |
| Allergan Inc. | $9,611 | 23 | $0 (2019) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $6,552 | 48 | $0 (2022) |
| ABBVIE INC. | $2,273 | 37 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $750.00 | 1 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $723.78 | 24 | $0 (2023) |
| Gilead Sciences, Inc. | $548.35 | 27 | $0 (2020) |
| Janssen Biotech, Inc. | $400.28 | 19 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,710 | 9 | CapsoVision, Inc. ($7,600) |
| 2023 | $18,804 | 22 | CapsoVision, Inc. ($18,725) |
| 2022 | $37,947 | 43 | CapsoVision, Inc. ($29,025) |
| 2021 | $42,120 | 20 | CapsoVision, Inc. ($27,300) |
| 2020 | $27,249 | 30 | CapsoVision, Inc. ($25,300) |
| 2019 | $22,339 | 70 | CapsoVision, Inc. ($20,000) |
| 2018 | $35,644 | 113 | CapsoVision, Inc. ($15,800) |
| 2017 | $16,895 | 79 | CapsoVision, Inc. ($8,300) |
All Payment Transactions
386 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | CapsoVision, Inc. | CapsoCam Colon (Device) | Consulting Fee | Cash or cash equivalent | $2,800.00 | General |
| Category: Gastroenterology | ||||||
| 11/22/2024 | CapsoVision, Inc. | CapsoCam Colon (Device) | Consulting Fee | Cash or cash equivalent | $1,675.00 | General |
| Category: Gastroenterology | ||||||
| 11/22/2024 | CapsoVision, Inc. | CapsoCam Colon (Device) | Consulting Fee | Cash or cash equivalent | $1,375.00 | General |
| Category: Gastroenterology | ||||||
| 11/22/2024 | CapsoVision, Inc. | CapsoCam Colon (Device) | Consulting Fee | Cash or cash equivalent | $1,275.00 | General |
| Category: Gastroenterology | ||||||
| 11/22/2024 | CapsoVision, Inc. | CapsoCam Colon (Device) | Consulting Fee | Cash or cash equivalent | $475.00 | General |
| Category: Gastroenterology | ||||||
| 07/24/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $27.73 | General |
| Category: Rare Disease | ||||||
| 04/17/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $27.41 | General |
| Category: Neuroscience | ||||||
| 02/06/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $31.89 | General |
| Category: THERAPY FOR CSID | ||||||
| 01/30/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $22.95 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/29/2023 | CapsoVision, Inc. | CapsoCam Plus (Device) | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| Category: Gastroenterology | ||||||
| 12/29/2023 | CapsoVision, Inc. | CapsoCam Plus (Device) | Consulting Fee | Cash or cash equivalent | $1,400.00 | General |
| Category: Gastroenterology | ||||||
| 10/13/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: IMMUNOLOGY | ||||||
| 10/11/2023 | CapsoVision, Inc. | CapsoCam Plus (Device) | Consulting Fee | Cash or cash equivalent | $1,400.00 | General |
| Category: Gastroenterology | ||||||
| 10/11/2023 | CapsoVision, Inc. | CapsoCam Plus (Device) | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| Category: Gastroenterology | ||||||
| 10/11/2023 | CapsoVision, Inc. | CapsoCam Plus (Device) | Consulting Fee | Cash or cash equivalent | $450.00 | General |
| Category: Gastroenterology | ||||||
| 10/10/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $26.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/16/2023 | CapsoVision, Inc. | CapsoCam Plus (Device) | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| Category: Gastroenterology | ||||||
| 08/16/2023 | CapsoVision, Inc. | CapsoCam Plus (Device) | Consulting Fee | Cash or cash equivalent | $1,100.00 | General |
| Category: Gastroenterology | ||||||
| 08/16/2023 | CapsoVision, Inc. | CapsoCam Plus (Device) | Consulting Fee | Cash or cash equivalent | $825.00 | General |
| Category: Gastroenterology | ||||||
| 07/06/2023 | CapsoVision, Inc. | CapsoCam Plus (Device) | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| Category: Gastroenterology | ||||||
| 07/06/2023 | CapsoVision, Inc. | CapsoCam Plus (Device) | Consulting Fee | Cash or cash equivalent | $1,300.00 | General |
| Category: Gastroenterology | ||||||
| 07/06/2023 | CapsoVision, Inc. | CapsoCam Plus (Device) | Consulting Fee | Cash or cash equivalent | $1,100.00 | General |
| Category: Gastroenterology | ||||||
| 07/06/2023 | CapsoVision, Inc. | CapsoCam Plus (Device) | Consulting Fee | Cash or cash equivalent | $375.00 | General |
| Category: Gastroenterology | ||||||
| 05/30/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $18.26 | General |
| Category: Neuroscience | ||||||
| 03/27/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Education | In-kind items and services | $15.35 | General |
| Category: INTERNAL MEDICINE | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A RANDOMIZED, MULTI-CENTER,, SUBJECT AND INVESTIGATOR BLINDED, PLACEBO CONTROLLED, PARALLEL GROUP PROOF OF CONCEPT STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF LYS006 IN PATIENTS WITH MILD TO MODERATE ULCERATIVE COLITIS | Novartis Pharmaceuticals Corporation | $750.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 944 | 1,898 | $422,625 | $157,517 |
| 2022 | 17 | 1,222 | 2,321 | $517,326 | $192,748 |
| 2021 | 18 | 1,164 | 2,053 | $470,425 | $182,693 |
| 2020 | 14 | 954 | 1,914 | $391,850 | $143,821 |
Total Patients
4,284
Total Services
8,186
Medicare Billing
$676,780
Procedure Codes
66
All Medicare Procedures & Services
66 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2023 | 89 | 95 | $71,250 | $34,196 | 48.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 127 | 243 | $29,160 | $19,898 | 68.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2023 | 44 | 44 | $43,780 | $14,307 | 32.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Office | 2023 | 32 | 32 | $38,400 | $13,977 | 36.4% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 125 | 386 | $57,900 | $12,179 | 21.0% |
| 91110 | Imaging of digestive tract done from the inside of the digestive tract | Office | 2023 | 12 | 12 | $18,000 | $8,547 | 47.5% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Office | 2023 | 29 | 29 | $27,550 | $8,336 | 30.3% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Office | 2023 | 18 | 19 | $18,050 | $7,151 | 39.6% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2023 | 88 | 232 | $34,800 | $6,941 | 19.9% |
| 76981 | Ultrasound scan of organ tissue for measuring elasticity | Office | 2023 | 63 | 68 | $17,000 | $6,585 | 38.7% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2023 | 89 | 291 | $29,100 | $6,581 | 22.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 44 | 49 | $7,585 | $5,518 | 72.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 32 | 32 | $7,200 | $4,902 | 68.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 41 | 41 | $6,150 | $4,166 | 67.7% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2023 | 93 | 305 | $15,250 | $3,212 | 21.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 18 | 20 | $1,450 | $1,019 | 70.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2022 | 113 | 117 | $87,750 | $44,951 | 51.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 162 | 272 | $32,570 | $23,819 | 73.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Office | 2022 | 43 | 43 | $51,600 | $20,103 | 39.0% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 148 | 458 | $68,700 | $15,228 | 22.2% |
| 91110 | Imaging of digestive tract done from the inside of the digestive tract | Office | 2022 | 15 | 15 | $22,500 | $11,732 | 52.1% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Office | 2022 | 35 | 35 | $33,250 | $11,706 | 35.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2022 | 38 | 38 | $37,810 | $10,323 | 27.3% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2022 | 108 | 273 | $40,950 | $8,404 | 20.5% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2022 | 111 | 355 | $35,500 | $8,327 | 23.5% |
About Dr. Jonathan Erber, MD
Dr. Jonathan Erber, MD is a Gastroenterology healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/03/2007. The National Provider Identifier (NPI) number assigned to this provider is 1730386657.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jonathan Erber, MD has received a total of $208,708 in payments from pharmaceutical and medical device companies, with $7,710 received in 2024. These payments were reported across 386 transactions from 27 companies. The most common payment nature is "Consulting Fee" ($172,015).
As a Medicare-enrolled provider, Erber has provided services to 4,284 Medicare beneficiaries, totaling 8,186 services with total Medicare billing of $676,780. Data is available for 4 years (2020–2023), covering 66 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Brooklyn, NY
- Active Since 07/03/2007
- Last Updated 12/17/2014
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1730386657
Products in Payments
- CapsoCam Plus (Device) $63,650
- CapsoCam Colon (Device) $19,000
- Trulance (Drug) $10,483
- LINZESS (Drug) $9,378
- XIFAXAN (Drug) $6,253
- PILLCAM (Device) $2,122
- LYS006X (Drug) $750.00
- Entyvio (Biological) $704.75
- Humira (Biological) $404.47
- STELARA (Biological) $381.63
- Cimzia (Drug) $306.90
- VIBERZI (Drug) $259.86
- UCERIS (Drug) $212.27
- XIFAXANIBSD (Drug) $182.99
- Olympus EndoTherapy Accessories (Device) $119.00
- TRULANCE (Drug) $117.22
- Fibroscan (Device) $107.24
- Mavyret (Drug) $96.07
- OCALIVA (Drug) $73.04
- GATTEX (Drug) $72.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Brooklyn
Sam Moskowitz, Md, MD
Gastroenterology — Payments: $349,162
Gastroenterology $349,162
Jianjun Li, M.d, M.D
Gastroenterology — Payments: $307,830
Gastroenterology $307,830
Dr. Nison Badalov, M.d, M.D
Gastroenterology — Payments: $237,374
Gastroenterology $237,374
Smruti Mohanty, Md, Ms, MD, MS
Gastroenterology — Payments: $219,216
Gastroenterology $219,216
Dr. Rabin Rahmani, M.d, M.D
Gastroenterology — Payments: $204,380
Gastroenterology $204,380
Kadirawelpillai Iswara, Md, MD
Gastroenterology — Payments: $191,623
Gastroenterology $191,623